Overview / Abstract: |
Treating patients with age-related macular degeneration can be challenging. This webinar features David E. Eichenbaum, MD, and Christina Y. Weng, MD, MBA, discussing newer compounds designed to improve visual outcomes and decrease treatment burden. Some of these agents, including several in the pipeline, have unique mechanisms of action that differ from those currently available. Drs. Eichenbaum and Weng provide the latest data on these novel treatment options and share challenging case studies. |
Expiration |
Apr 30, 2022 |
Discipline(s) |
Optometry / Ophthalmology CE |
Format |
Webinar / Webcast / Video |
Accreditation |
ACCME |
Keywords / Search Terms |
Evolve Medical Education LLC Free CE CME |